NAD+ Therapy: IV, NMN, and NR Explained for High-Performers

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It plays a central role in energy metabolism, DNA repair, and cellular signaling. By age 50, NAD+ levels have declined by approximately 50% compared to young adulthood, and this decline is associated with many hallmarks of aging: reduced mitochondrial function, impaired DNA repair, and chronic low-grade inflammation.

The wellness industry has responded with a flood of NAD+ products: oral supplements, sublingual tablets, transdermal patches, and intravenous infusions. Prices range from $20 per month for oral precursors to $1,000+ per IV session. The marketing claims far outpace the clinical evidence for most of these products.

This guide examines the three primary NAD+ supplementation strategies, what the research actually shows, and how to evaluate whether NAD+ therapy is appropriate for your health goals. As with all interventions discussed on this site, this information is for educational purposes and should be discussed with a qualified healthcare provider before making any decision.

What NAD+ Does in the Body

NAD+ functions as an electron carrier in metabolic reactions. Every time your cells convert nutrients into ATP (the energy currency of the cell), NAD+ shuttles electrons through the mitochondrial electron transport chain. Without sufficient NAD+, mitochondrial ATP production slows.

Beyond energy metabolism, NAD+ serves as a substrate for several critical enzymes:

✦PARP enzymes: These repair DNA damage. PARP activity consumes NAD+, meaning that cells under oxidative stress (from poor diet, environmental toxins, or intense physical training) deplete NAD+ faster.
✦Sirtuins (SIRT1-7): These proteins regulate cellular healthspan by influencing inflammation, mitochondrial biogenesis, and circadian rhythm. Sirtuin activation requires NAD+, which is why declining NAD+ levels are theorized to reduce sirtuin activity with age.
✦CD38: An immune cell enzyme that also consumes NAD+. Chronic inflammation increases CD38 activity, further depleting cellular NAD+.

The relationship between NAD+ and aging is an active area of research. Animal studies consistently show that restoring NAD+ levels in aged mice improves markers of metabolic health, muscle function, and neuroprotection. Human trials are more mixed, with some showing benefits and others showing no significant effects.

Oral Precursors: NMN and NR

Direct oral supplementation with NAD+ itself is ineffective because the NAD+ molecule is too large to cross cell membranes intact and is degraded in the digestive tract. Instead, supplement manufacturers use precursor molecules that cells can convert into NAD+.

Nicotinamide Riboside (NR)

NR is a form of vitamin B3 that cells convert to NAD+ through a two-step salvage pathway. It is the most clinically studied NAD+ precursor in humans. Multiple double-blind, placebo-controlled trials have confirmed that oral NR supplementation raises blood NAD+ levels by 40-90% depending on dose and duration.

Key findings from NR research:

✦A 2018 study published in *Nature Communications* demonstrated that NR supplementation at 1,000 mg per day for 8 weeks safely raised NAD+ levels in healthy older adults without serious adverse events.
✦A 2019 study in the *American Journal of Clinical Nutrition* found that NR supplementation reduced markers of inflammation in aged adults, though the clinical significance of these biomarker changes remains unclear.
✦A 2021 trial published in *The Journals of Gerontology* found no improvement in insulin sensitivity or blood pressure in older adults taking 1,000 mg NR daily for 12 weeks, despite confirmed NAD+ elevation.

The consistent finding across NR trials is that it reliably raises NAD+ levels but the downstream clinical benefits in healthy adults are modest or absent. Most researchers agree that NR supplementation appears safe in the short to medium term, but evidence for meaningful health outcomes in non-diseased populations is limited.

Nicotinamide Mononucleotide (NMN)

NMN is a direct precursor to NAD+ that is one step closer in the biosynthetic pathway than NR. It has been less studied in humans than NR, but interest surged after Dr. David Sinclair's lab at Harvard published influential animal studies showing lifespan and healthspan benefits in mice.

Human data on NMN is growing but still limited:

✦A 2022 study in *Science* found that NMN supplementation at 250 mg per day improved insulin sensitivity and markers of muscle function in aged adults with prediabetes.
✦A 2023 study in *Nutrients* showed that NMN improved walking endurance and reduced daytime sleepiness in older adults.
✦Multiple ongoing trials are investigating NMN's effects on cardiovascular health, cognitive function, and metabolic syndrome.

NMN is generally well-tolerated in published trials. However, the body of human evidence is smaller than for NR, and long-term safety data (beyond 12-24 weeks) is not yet available.

NMN vs NR: Which Is Better?

This is one of the most common questions in NAD+ supplementation. The honest answer is that there is no definitive head-to-head comparison in humans showing one is superior. Both raise NAD+ levels. Both appear safe in short-term studies. NR has more human safety data. NMN has more recent clinical trial momentum, particularly in aged populations.

Some researchers argue that NMN is theoretically superior because it bypasses one enzymatic step in the NAD+ salvage pathway. Others argue that NR is more bioavailable because it enters cells through a specific nucleoside transporter. Neither argument has been conclusively proven in human trials.

For patients interested in the foundational science behind peptide and supplement optimization, our guide on what are peptides provides broader context on how cellular-level interventions work.

IV NAD+ Therapy

Intravenous NAD+ infusion delivers the coenzyme directly into the bloodstream, bypassing the digestive system entirely. This approach achieves NAD+ blood levels far higher than any oral precursor, at least in the hours following infusion. IV NAD+ therapy has become popular in wellness clinics, addiction recovery programs, and anti-aging practices.

What the Evidence Shows

The clinical evidence for IV NAD+ is thinner than the enthusiasm suggests. Most published studies on IV NAD+ have been small, uncontrolled, or focused on specific populations (substance use disorder, chronic fatigue syndrome). Key findings:

✦A 2019 pilot study found that IV NAD+ reduced cravings and withdrawal symptoms in opioid-dependent patients, but the study had no control group.
✦Several small studies suggest IV NAD+ may improve fatigue and cognitive symptoms in chronic fatigue syndrome patients, but these findings have not been replicated in large randomized trials.
✦No large-scale, double-blind, placebo-controlled trial has demonstrated that IV NAD+ provides meaningful clinical benefits in healthy adults.

The theoretical appeal of IV NAD+ is that it achieves supraphysiological blood levels, which may reach tissues that oral precursors cannot saturate. However, whether this translates to durable clinical benefit is unproven. NAD+ has a short half-life in blood, and the elevated levels from a single infusion return to baseline within hours to days.

Cost and Practical Considerations

IV NAD+ therapy typically costs $400-$1,000+ per session, with clinics recommending a series of 4-8 sessions for "loading." This represents a significant investment for an intervention with limited evidence of sustained benefit.

Common side effects during IV NAD+ infusion include nausea, flushing, chest tightness, and cramping. These are dose-dependent and usually resolve when the infusion rate is slowed. More serious adverse events are rare but documented, including cardiac arrhythmia at high infusion rates.

Who Might Benefit

IV NAD+ therapy is most defensible for patients with documented mitochondrial dysfunction, chronic fatigue conditions, or substance use recovery protocols under physician supervision. For healthy adults seeking general optimization, the evidence does not justify the cost relative to oral precursors, especially given that our understanding of NAD+ in weight loss and metabolism is still evolving. For related reading on metabolic optimization, see our comparison of GLP-1 weight loss options.

Sublingual and Transdermal NAD+

Several products deliver NAD+ or its precursors through sublingual (under the tongue) or transdermal (skin patch) routes. The rationale is that these routes bypass first-pass liver metabolism, potentially increasing bioavailability.

The evidence for these delivery methods is minimal. No published peer-reviewed trial has demonstrated that sublingual or transdermal NAD+ is superior to oral NR or NMN in raising tissue NAD+ levels. These products may be convenient, but they should not be assumed to be more effective than well-studied oral supplements based on current evidence.

How to Evaluate NAD+ Products

When evaluating any NAD+ supplement or therapy, apply these criteria:

✦Look for third-party testing. Quality supplement manufacturers provide certificates of analysis from independent labs verifying purity and potency. NAD+ precursors are not FDA-regulated as drugs, so product quality varies widely.
✦Check the form of the precursor. Products labeled "NAD+" or "NADH" in oral form are unlikely to be effective because the molecule degrades in digestion. Look for NR (often labeled as "nicotinamide riboside chloride" or "Niagen") or NMN.
✦Be skeptical of stacking claims. Some products combine NAD+ precursors with other supplements (resveratrol, pterostilbene, quercetin) and claim synergistic benefits. While there is theoretical rationale for some combinations (sirtuin activators paired with NAD+ precursors), human evidence for these stacks is lacking. Our guide on peptide stacking protocols covers similar considerations in peptide therapy.
✦Consider dosing transparency. Products that list a "proprietary blend" without disclosing the amount of NR or NMN per serving make it impossible to compare against clinical trial doses (typically 250-1,000 mg per day).

NAD+ and Lifestyle Factors

Supplementation is only one lever. Several lifestyle interventions have been shown to naturally raise NAD+ levels:

✦Caloric restriction and intermittent fasting: Both have been demonstrated to increase NAD+ levels and sirtuin activity in human studies. The effect is modest but consistent.
✦High-intensity interval training (HIIT): Exercise increases NAMPT enzyme activity, which is the rate-limiting step in the NAD+ salvage pathway. Regular exercise is the most reliable non-pharmacological way to maintain NAD+ levels.
✦Heat exposure (sauna): Some evidence suggests that regular sauna use increases NAD+ levels through heat-shock protein activation, though human data is limited.
✦Sleep optimization: NAD+ levels follow a circadian rhythm, and chronic sleep disruption has been shown to deplete NAD+ in animal models.

These interventions are free, well-supported by evidence, and should form the foundation of any NAD+ optimization strategy before supplementation is considered.

The LuxeFit Wellness Approach

At LuxeFit Wellness, we approach NAD+ therapy as part of a comprehensive metabolic optimization strategy. Our physicians evaluate patients individually, considering age, metabolic markers, training intensity, and overall health status before recommending any supplementation protocol.

We do not believe in one-size-fits-all NAD+ protocols. The decision between oral precursors and IV therapy depends on individual factors that require professional evaluation. Patients interested in NAD+ optimization should first address foundational lifestyle factors (sleep, exercise, nutrition) and then discuss supplementation options with a qualified healthcare provider.

Schedule a consultation to discuss whether NAD+ therapy is appropriate for your health and performance goals.

*Disclaimer: This article is for informational purposes only and does not constitute medical advice. NMN and NR are dietary supplements, not FDA-approved medications, and have not been evaluated by the FDA for safety or efficacy in the treatment of any medical condition. IV NAD+ therapy should only be administered under the supervision of a qualified healthcare provider. Individual results vary. Always consult a licensed healthcare provider before starting, stopping, or changing any supplement or therapy regimen. LuxeFit Wellness does not guarantee specific outcomes from any therapy.*